Abstract
Malignant blast cells in the various forms of acute leukaemia seem to be ‘frozen’ at early stages of haematopoietic and lymphoid cell maturation. These blasts express relatively stable morphological, enzymatic and antigenic phenotypes which may largely represent the normal gene products of the corresponding precursor cells1–4. A number of findings support these suggestions. The phenotype of the common form of acute lymphoblastic leukaemia (cALL) corresponds to the phenotype of normal small non-T, non-B cells of lymphoid morphology detected in low numbers in the normal and regenerating infant bone marrow4,5. Also, the phenotype of blast cells in Thy-ALL corresponds approximately to that of cortical thymocytes or their immediate precursors6–9. Leukaemia-specific (virus-induced or mutant) changes or aberrant expression of normal gene products may also occur in leukaemia. To describe such phenomena, detailed single cell studies comparing leukaemic cells with their appropriate normal (frequently very rare) counterparts are needed. In this study we have performed such a comparative study and find that the human Thy-ALL blasts express unexpectedly high amounts of HLA-A, -B and -C antigens: the sensitive single cell assays used failed to find normal cells (in infant and fetal thymus, and in bone marrow) which express the exact phenotype of Thy-ALL blasts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sachs, L. Nature 274, 535–539 (1978).
Metcalf, P. & Moore, M. A. S. in Haemopoietic Cells (North Holland, Amsterdam, 1971).
Salmon, S. E. & Seligmann, M. Lancet ii, 1230–1233 (1974).
Greaves, M. F. & Janossy, G. Biochim. biophys. Acta 516, 193–230 (1978).
Janossy, G. et al. J. Immun. 123, 1525–1529 (1979).
Mills, B., Sen, L. & Borella, L. J. Immun. 115, 1038–1044 (1975).
Stein, H. et al. Int. J. Cancer. 17, 292–295 (1976).
Bradstock, K. F. et al. J. natn. Cancer Inst. (in the press).
Reinherz, E. L., Kung, P. C., Goldstein, G. & Schlossman, S. F. Proc. natn. Acad. Sci. U.S.A. (in the press).
Bollum, F. J. Proc. natn. Acad. Sci. U.S.A. 72, 4119–4122 (1975).
Barnstable, C. J. et al. Cell 14, 9–21 (1978).
McMichael, A. J. et al. Eur. J. Immun. 9, 205–210 (1979).
Gatien, J. G., Schneeburger, E. E. & Merlar, E. Eur. J. Immun. 5, 312–317 (1975).
Sugimoto, M. & Bollum, F. J. J. Immun. 122, 392–397 (1979).
Gregoire, K. E., Goldschneider, I., Barton, R. W. & Bollum, F. J. J. Immun. 123, 1347–1357 (1979).
Brown, G., Biberfeld, P., Christensen, B. & Mason, D. Y. Eur. J. Immun. 9, 272–275 (1979).
Janossy, G. et al. J. Immunol. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bradstock, K., Janossy, G., Bollum, F. et al. Anomalous phenotype in thymic acute lymphoblastic leukaemia. Nature 284, 455–457 (1980). https://doi.org/10.1038/284455a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/284455a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.